BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17546598)

  • 1. Gene therapy using ets-1 transcription factor decoy for peritoneal dissemination of gastric cancer.
    Taniguchi H; Fujiwara Y; Doki Y; Sugita Y; Sohma I; Miyata H; Takiguchi S; Yasuda T; Tomita N; Morishita R; Monden M
    Int J Cancer; 2007 Oct; 121(7):1609-17. PubMed ID: 17546598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer.
    Namiki Y; Namiki T; Yoshida H; Date M; Yashiro M; Matsumoto K; Nakamura T; Yanagihara K; Tada N; Satoi J; Fujise K
    Int J Cancer; 2006 Mar; 118(6):1545-55. PubMed ID: 16206271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.
    Matsui Y; Inomata M; Tojigamori M; Sonoda K; Shiraishi N; Kitano S
    Int J Oncol; 2005 Sep; 27(3):681-5. PubMed ID: 16077916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
    Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
    Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.
    Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H
    Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis.
    Tokuyama J; Kubota T; Saikawa Y; Yoshida M; Furukawa T; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2005; 25(1A):17-22. PubMed ID: 15816514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice.
    Kamiyama M; Ichikawa Y; Ishikawa T; Chishima T; Hasegawa S; Hamaguchi Y; Nagashima Y; Miyagi Y; Mitsuhashi M; Hyndman D; Hoffman RM; Ohki S; Shimada H
    Cancer Gene Ther; 2002 Feb; 9(2):197-201. PubMed ID: 11857038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
    Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
    Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
    Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
    Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
    Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity.
    Li MY; Zhu M; Feng F; Cai FY; Fan KC; Jiang H; Wang ZQ; Linghu EQ
    Genet Mol Res; 2014 Apr; 13(3):6981-94. PubMed ID: 24782214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
    Zhu Y; Cheng M; Yang Z; Zeng CY; Chen J; Xie Y; Luo SW; Zhang KH; Zhou SF; Lu NH
    Drug Des Devel Ther; 2014; 8():2449-62. PubMed ID: 25525335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model.
    Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.
    Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
    Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
    Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Ninomiya I; Ohta T
    BMC Cancer; 2017 Jan; 17(1):23. PubMed ID: 28056854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
    Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
    Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion.
    Mino K; Ozaki M; Nakanishi K; Haga S; Sato M; Kina M; Takahashi M; Takahashi N; Kataoka A; Yanagihara K; Ochiya T; Kamiyama T; Umezawa K; Todo S
    Cancer Sci; 2011 May; 102(5):1052-8. PubMed ID: 21288284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.
    Wang XL; Chen XM; Fang JP; Yang CQ
    Acta Pharmacol Sin; 2012 Apr; 33(4):513-22. PubMed ID: 22407230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.